Skip to main content

 Related scientific articles (all)

Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review.

Authors : Sangro B, Martínez-Urbistondo D, Bester L, Bilbao JI, Coldwell DM, Flamen P, Kennedy A, Ricke J, Sharma RA
Year : 2017
Journal : Hepatology
Volume : 66(3)
Pages : 969-982

Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).

Authors : Loibl S, de la Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, Bermejo B, Untch M, Lee SC, Turri S, Urban P, Kümmel S, Steger G, Gombos A, Lux M, Piccart-Gebhart M, Von Minckwitz G, Baselga J, Loi S
Year : 2017
Journal : Eur J Cancer
Volume : 85
Pages : 133-145

Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.

Authors : Buisseret L, Desmedt C, Garaud S, Fornili M, Wang X, Van den Eyden G, de Wind A, Duquenne S, Boisson A, Naveaux C, Rothé F, Rorive S, Decaestecker C, Larsimont D, Piccart-Gebhart M, Biganzoli E, Sotiriou C, Willard-Gallo K
Year : 2017
Journal : Mod Pathol
Volume : 30(9)
Pages : 1204-1212

Predictors of physicians' communication performance in a decision-making encounter with a simulated advanced-stage cancer patient: A longitudinal study.

Authors : Libert Y, Canivet D, Ménard C, Van Achte L, Farvacques C, Merckaert I, Liénard A, Klastersky J, Reynaert C, Slachmuylder JL, Durieux JF, Delvaux N, Razavi D
Year : 2017
Journal : Patient Educ Couns
Volume : 100(9)
Pages : 1672-9

Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications.

Authors : Solinas C, Pusole G, Demurtas L, Puzzoni M, Mascia R, Morgan G, Giampieri R, Scartozzi M
Year : 2017
Journal : Crit Rev Oncol Hematol
Volume : 110
Pages : 106-116

Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.

Authors : Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron D, Bodaghi B, LeHoang P, Bergstrom C, Grossniklaus HE, Chan CC, Peer J, Caspers LE
Year : 2017
Journal : Ocul Immunol Inflamm
Volume : 25(5)
Pages : 639-648

Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.

Authors : El Rassy E, Aoun F, Sleilaty G, Kattan J, Banyurwabuke B, Zanaty M, Bakouny Z, Albisinni S, Peltier A, Roumeguere T
Year : 2017
Journal : Future Oncol
Volume : 13
Pages : 2709-2717

Legends in Urology.

Authors : Van Velthoven R
Year : 2017
Journal : Can J Urol
Volume : 24
Pages : 8872-8874

P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition.

Authors : Najem A, Krayem M, Sales F, Hussein N, Badran B, Robert C, Awada A, Journe F, Ghanem G
Year : 2017
Journal : Eur J Cancer
Volume : 83
Pages : 154-165

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.

Authors : Gingras I, Holmes E, de Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart-Gebhart M, Azim HA Jr
Year : 2017
Journal : J Natl Cancer Inst
Volume : 109

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

Authors : Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Pernault-Llorca F, Piccart-Gebhart M, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E
Year : 2017
Journal : Breast
Volume : 31
Pages : 244-259

Extra-osseous Ewing sarcoma of the thyroid gland mimicking a hemorrhagic cyst of Hashimoto thyroiditis

Authors : El Hachem G, Jungels C, de Saint-Aubain de Somerhausen N, Awada A, Gil T
Year : 2017
Journal : Journal of clinical reviews and case reports
Volume : 1(1)
Pages : -

Editorial.

Authors : Berghmans T
Year : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 3

From skeletal muscle to stem cells: an innovative and minimally-invasive process for multiple species.

Authors : Ceusters J, Lejeune JP, Sandersen C, Niesten A, Lagneaux L, Serteyn D
Year : 2017
Journal : Sci Rep
Volume : 7
Pages : 696

Impact of dermatologic adverse events induced by targeted therapies on quality of life.

Authors : Charles C, Bungener C, Razavi D, Mateus C, Routier E, Lanoy E, Verschoore M, Robert C, Dauchy S
Year : 2016
Journal : Crit Rev Oncol Hematol
Volume : 101
Pages : 158-68

Belgium recommendations for the management of acute promyelocytic leukaemia

Authors : Wittnebel S
Year : 2016
Journal : Belgian J Hematology
Volume : 7
Pages : 224-8

Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs.

Authors : Fadoukhair Z, Zardavas D, Chad MA, Goulioti T, Aftimos P, Piccart-Gebhart M
Year : 2016
Journal : Oncogene
Volume : 35(14)
Pages : 1743-9

Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.

Authors : Vanderveken OM, Szturz P, Specenier P, Merlano MC, Benasso M, Van Gestel D, Wouters K, Van Laer C, Van den Weyngaert D, Peeters M, Vermorken J
Year : 2016
Journal : Oncologist
Volume : 21
Pages : 59-71

Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.

Authors : Kourie HR, Ameye L, Paesmans M, Bron D
Year : 2016
Journal : Ann Hematol
Volume : 95(12)
Pages : 2105-2106

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors : Krop IE, Mayer IA, Ganju V, Dickler M, Johnston S, Morales S, Yardley DA, Melichar B, Forero-Torres A, Lee SC, de Boer R, Petrakova K, Vallentin S, Perez EA, Piccart-Gebhart M, Ellis M, Winer E, Gendreau S, Derynck M, Lackner M, Levy G, Qiu J, He J, Schmid P
Year : 2016
Journal : Lancet Oncol
Volume : 17
Pages : 811-21